Sponastrime dysplasia
Sponastrime dysplasia is a rare genetic disorder characterized by various skeletal abnormalities, growth retardation, and distinctive facial features. It was first described in the medical literature by Spranger et al. in 1980. The term "sponastrime" is an acronym derived from the major features of the disorder: spondylar abnormalities, nasal hypoplasia, striations of the metaphysis, and metaphyseal dysplasia.
Clinical Features[edit | edit source]
The clinical features of sponastrime dysplasia are variable and may differ significantly among affected individuals. However, common features include:
- Growth Retardation: Affected individuals often exhibit prenatal and postnatal growth retardation, resulting in short stature.
- Skeletal Abnormalities: These may include scoliosis, kyphosis, pectus carinatum, and various abnormalities of the hands, feet, and limbs.
- Facial Features: Distinctive facial features may include a prominent forehead, a flat nasal bridge, and a small, upturned nose.
Genetics[edit | edit source]
Sponastrime dysplasia is believed to be an autosomal recessive disorder, which means that two copies of an abnormal gene must be present in order for the disease or trait to develop. The exact genetic cause of the disorder is currently unknown.
Diagnosis[edit | edit source]
Diagnosis of sponastrime dysplasia is based on a thorough clinical evaluation, detailed patient history, and a variety of specialized tests. These may include advanced imaging techniques, such as computed tomography (CT) scans and magnetic resonance imaging (MRI), to detect characteristic abnormalities associated with the disorder.
Treatment[edit | edit source]
There is currently no cure for sponastrime dysplasia. Treatment is symptomatic and supportive, and may include physical therapy, surgical intervention for skeletal abnormalities, and other supportive measures.
See Also[edit | edit source]
This rare disease-related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD